SPS
RGNX icon

Susquehanna Portfolio Strategies’s Regenxbio RGNX Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43M Sell
119,471
-67,130
-36% -$557K 0.02% 496
2026
Q1 		$1.56M Buy
186,601
+53,045
+40% +$557K 0.02% 553
2025
Q4 		$1.92M Hold
133,556
– – 0.03% 513
2025
Q3 		$1.29M Buy
+133,556
New +$1.18M 0.02% 617

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Susquehanna Portfolio Strategies's RGNX Position: Q2 2026 in Review

Susquehanna Portfolio Strategies reduced its Regenxbio (RGNX) stake by 36% in Q2 2026, selling an estimated $557K and leaving 119,471 shares worth $1.43M. The position accounts for 0.02% of the portfolio, ranked #496.

Susquehanna Portfolio Strategies first reported a position in RGNX in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.92M in Q4 2025. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Susquehanna Portfolio Strategies held 119,471 shares of Regenxbio worth $1.43M as of Q2 2026.
  • Susquehanna Portfolio Strategies sold 67,130 Regenxbio shares in Q2 2026, an estimated $557K.
  • Regenxbio made up 0.02% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #496 holding.
  • Susquehanna Portfolio Strategies first reported a position in Regenxbio in Q3 2025 and has held it in 4 quarters since.
  • Susquehanna Portfolio Strategies's Regenxbio position peaked at $1.92M in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.